Substituted (4'-hydroxyphenyl)cyclohexane compounds and uses thereof as selective agonists of the estrogen receptor beta isoform
US10570077B2 · kind B2 · utility
0Cited by
6References
19Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | May 23, 2016 |
| Grant date | Feb 25, 2020 |
| Priority date | — |
| Expiry date | Nov 22, 2036 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07C2601/18
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
Disclosed are substituted (4′-hydroxylphenyl)cycloalkane compounds and there use as selective agonists of the estrogen receptor beta isoform (ERβ). The disclosed compounds may be formulated as pharmaceutical compositions and administered to treat diseases associated with ER activity, such as proliferative diseases and disorders and/or psychiatric diseases or disorders.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.